Please enable JavaScript to continue using this application.

Compare $IOVA vs $PRAX | Chartloom

Compare

$IOVA vs $PRAX

Iovance Biotherapeutics Inc · Praxis Precision Medicines Inc

IOVA

Iovance Biotherapeutics Inc

PRAX

Praxis Precision Medicines Inc

Compare $IOVA vs $PRAX

Comparing Iovance Biotherapeutics Inc and Praxis Precision Medicines Inc

IOVAIovance Biotherapeutics Inc

PRAXPraxis Precision Medicines Inc

IOVAIovance Biotherapeutics Inc

Market cap

$6.53B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

12.69x

Rev growth (TTM)

34.5%

YTD performance

480.2%

52W performance

544.1%

FCF yield

-4.5%

PRAXPraxis Precision Medicines Inc

Market cap

$7.24B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

67.04x

Rev growth (TTM)

—

YTD performance

-9.3%

52W performance

378.7%

FCF yield

-4.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IOVA

PRAX

Detailed metrics comparison

IOVA

Iovance Biotherapeutics Inc

PRAX

Praxis Precision Medicines Inc

Market Cap

IOVA$6.53B

PRAX$7.24B

Enterprise Value

IOVA$6.42B

PRAX$6.77B

Price

IOVA$14.62

PRAX$259.86

P/E Ratio

IOVAN/A

PRAXN/A

P/S Ratio

IOVA20.09x

PRAX964.65x

EV/Sales

IOVA19.75x

PRAX909.14x

EV/EBITDA

IOVA0.00x

PRAX0.00x

P/B Ratio

IOVA8.75x

PRAX6.15x

P/FCF Ratio

IOVAN/A

PRAXN/A

EV/FCF

IOVA-21.65x

PRAX-22.11x

PEG Ratio

IOVAN/A

PRAXN/A

Forward P/E (NTM)

IOVAN/A

PRAXN/A

Forward P/S (NTM)

IOVA12.69x

PRAX67.04x

Revenue (TTM)

IOVA$325M

PRAX$0

Revenue Growth (YoY)

IOVA34.5%

PRAXN/A

Forward Rev Growth

IOVA39.2%

PRAX38349.0%

Gross Margin (TTM)

IOVA48.4%

PRAX0.0%

Operating Margin (TTM)

IOVA0.0%

PRAX0.0%

EBITDA Margin (TTM)

IOVA-79.8%

PRAX0.0%

Net Margin (TTM)

IOVA-89.1%

PRAX0.0%

FCF Margin (TTM)

IOVA-91.2%

PRAXN/A

Net Income (TTM)

IOVA$-290M

PRAX$-255M

FCF (TTM)

IOVA$-296M

PRAX$-306M

EPS (TTM)

IOVA-$0.64

PRAX$0.00

ROE (TTM)

IOVA-4051.0%

PRAX-4302.0%

ROA (TTM)

IOVA-3165.0%

PRAX-4022.0%

ROIC (TTM)

IOVA-4047.0%

PRAX-4302.0%

Cash

IOVA$111M

PRAX$475M

Debt

IOVA$0

PRAX$0

Net Cash/Debt

IOVA$111M

PRAX$475M

Current Ratio (TTM)

IOVA4.35x

PRAX15.73x

Quick Ratio (TTM)

IOVA3.74x

PRAX15.46x

Debt/Equity (TTM)

IOVA0.00x

PRAX0.00x

Debt/Assets (TTM)

IOVA0.0%

PRAX0.0%

Interest Coverage (TTM)

IOVAN/A

PRAXN/A

Net Debt/EBITDA (TTM)

IOVA0.00x

PRAX0.00x

Beta

IOVA0.76

PRAX2.88

52W Performance

IOVA544.1%

PRAX378.7%

YTD Performance

IOVA480.2%

PRAX-9.3%

% from 52W High

IOVA-4.4%

PRAX-33.8%

% from 52W Low

IOVA730.7%

PRAX414.0%

Asset Turnover (TTM)

IOVA0.36x

PRAX0.02x

FCF Yield (TTM)

IOVA-4.5%

PRAX-4.2%

Earnings Yield (TTM)

IOVA-4.4%

PRAX-3.5%

Dividend Yield (TTM)

IOVAN/A

PRAXN/A

Rule of 40

IOVA-56.7

PRAX0.0

EV/GP/RG

IOVA0.68

PRAXN/A

Ticker research

View IOVA research View PRAX research

Metric	IOVA Iovance Biotherapeutics Inc	PRAX Praxis Precision Medicines Inc
Market & Valuation
Market Cap	$6.53B	$7.24B
Enterprise Value	$6.42B	$6.77B
Price	$14.62	$259.86
P/E Ratio	N/A	N/A
P/S Ratio	20.09x	964.65x
EV/Sales	19.75x	909.14x
EV/EBITDA	0.00x	0.00x
P/B Ratio	8.75x	6.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-21.65x	-22.11x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.69x	67.04x
Revenue & Growth
Revenue (TTM)	$325M	$0
Revenue Growth (YoY)	34.5%	N/A
Forward Rev Growth	39.2%	38349.0%
Profitability
Gross Margin (TTM)	48.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-79.8%	0.0%
Net Margin (TTM)	-89.1%	0.0%
FCF Margin (TTM)	-91.2%	N/A
Net Income (TTM)	$-290M	$-255M
FCF (TTM)	$-296M	$-306M
EPS (TTM)	-$0.64	$0.00
ROE (TTM)	-4051.0%	-4302.0%
ROA (TTM)	-3165.0%	-4022.0%
ROIC (TTM)	-4047.0%	-4302.0%
Financial Health
Cash	$111M	$475M
Debt	$0	$0
Net Cash/Debt	$111M	$475M
Current Ratio (TTM)	4.35x	15.73x
Quick Ratio (TTM)	3.74x	15.46x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.76	2.88
52W Performance	544.1%	378.7%
YTD Performance	480.2%	-9.3%
% from 52W High	-4.4%	-33.8%
% from 52W Low	730.7%	414.0%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.02x
FCF Yield (TTM)	-4.5%	-4.2%
Earnings Yield (TTM)	-4.4%	-3.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-56.7	0.0
EV/GP/RG	0.68	N/A
Ticker research	View IOVA research	View PRAX research

Valuation

P/S Ratio

IOVA

20.09x

PRAX

964.65x

EV/FCF

PRAX

-22.11x

IOVA

-21.65x

Growth & revenue

Revenue Growth TTM

IOVA

34.5%

Forward Revenue Growth

PRAX

38349.0%

IOVA

39.2%

Profitability & performance

Gross Margin

IOVA

48.4%

PRAX

0.0%

ROE

IOVA

-4051.0%

PRAX

-4302.0%

FCF Yield %

PRAX

-4.2%

IOVA

-4.5%

52-Week Performance

IOVA

544.1%

PRAX

378.7%

Detailed metrics comparison

IOVA

Iovance Biotherapeutics Inc

PRAX

Praxis Precision Medicines Inc

Market Cap

IOVA$6.53B

PRAX$7.24B

Enterprise Value

IOVA$6.42B

PRAX$6.77B

Price

IOVA$14.62

PRAX$259.86

P/E Ratio

IOVAN/A

PRAXN/A

P/S Ratio

IOVA20.09x

PRAX964.65x

EV/Sales

IOVA19.75x

PRAX909.14x

EV/EBITDA

IOVA0.00x

PRAX0.00x

P/B Ratio

IOVA8.75x

PRAX6.15x

P/FCF Ratio

IOVAN/A

PRAXN/A

EV/FCF

IOVA-21.65x

PRAX-22.11x

PEG Ratio

IOVAN/A

PRAXN/A

Forward P/E (NTM)

IOVAN/A

PRAXN/A

Forward P/S (NTM)

IOVA12.69x

PRAX67.04x

Revenue (TTM)

IOVA$325M

PRAX$0

Revenue Growth (YoY)

IOVA34.5%

PRAXN/A

Forward Rev Growth

IOVA39.2%

PRAX38349.0%

Gross Margin (TTM)

IOVA48.4%

PRAX0.0%

Operating Margin (TTM)

IOVA0.0%

PRAX0.0%

EBITDA Margin (TTM)

IOVA-79.8%

PRAX0.0%

Net Margin (TTM)

IOVA-89.1%

PRAX0.0%

FCF Margin (TTM)

IOVA-91.2%

PRAXN/A

Net Income (TTM)

IOVA$-290M

PRAX$-255M

FCF (TTM)

IOVA$-296M

PRAX$-306M

EPS (TTM)

IOVA-$0.64

PRAX$0.00

ROE (TTM)

IOVA-4051.0%

PRAX-4302.0%

ROA (TTM)

IOVA-3165.0%

PRAX-4022.0%

ROIC (TTM)

IOVA-4047.0%

PRAX-4302.0%

Cash

IOVA$111M

PRAX$475M

Debt

IOVA$0

PRAX$0

Net Cash/Debt

IOVA$111M

PRAX$475M

Current Ratio (TTM)

IOVA4.35x

PRAX15.73x

Quick Ratio (TTM)

IOVA3.74x

PRAX15.46x

Debt/Equity (TTM)

IOVA0.00x

PRAX0.00x

Debt/Assets (TTM)

IOVA0.0%

PRAX0.0%

Interest Coverage (TTM)

IOVAN/A

PRAXN/A

Net Debt/EBITDA (TTM)

IOVA0.00x

PRAX0.00x

Beta

IOVA0.76

PRAX2.88

52W Performance

IOVA544.1%

PRAX378.7%

YTD Performance

IOVA480.2%

PRAX-9.3%

% from 52W High

IOVA-4.4%

PRAX-33.8%

% from 52W Low

IOVA730.7%

PRAX414.0%

Asset Turnover (TTM)

IOVA0.36x

PRAX0.02x

FCF Yield (TTM)

IOVA-4.5%

PRAX-4.2%

Earnings Yield (TTM)

IOVA-4.4%

PRAX-3.5%

Dividend Yield (TTM)

IOVAN/A

PRAXN/A

Rule of 40

IOVA-56.7

PRAX0.0

EV/GP/RG

IOVA0.68

PRAXN/A

Ticker research

View IOVA research View PRAX research

Metric	IOVA Iovance Biotherapeutics Inc	PRAX Praxis Precision Medicines Inc
Market & Valuation
Market Cap	$6.53B	$7.24B
Enterprise Value	$6.42B	$6.77B
Price	$14.62	$259.86
P/E Ratio	N/A	N/A
P/S Ratio	20.09x	964.65x
EV/Sales	19.75x	909.14x
EV/EBITDA	0.00x	0.00x
P/B Ratio	8.75x	6.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-21.65x	-22.11x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.69x	67.04x
Revenue & Growth
Revenue (TTM)	$325M	$0
Revenue Growth (YoY)	34.5%	N/A
Forward Rev Growth	39.2%	38349.0%
Profitability
Gross Margin (TTM)	48.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-79.8%	0.0%
Net Margin (TTM)	-89.1%	0.0%
FCF Margin (TTM)	-91.2%	N/A
Net Income (TTM)	$-290M	$-255M
FCF (TTM)	$-296M	$-306M
EPS (TTM)	-$0.64	$0.00
ROE (TTM)	-4051.0%	-4302.0%
ROA (TTM)	-3165.0%	-4022.0%
ROIC (TTM)	-4047.0%	-4302.0%
Financial Health
Cash	$111M	$475M
Debt	$0	$0
Net Cash/Debt	$111M	$475M
Current Ratio (TTM)	4.35x	15.73x
Quick Ratio (TTM)	3.74x	15.46x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.76	2.88
52W Performance	544.1%	378.7%
YTD Performance	480.2%	-9.3%
% from 52W High	-4.4%	-33.8%
% from 52W Low	730.7%	414.0%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.02x
FCF Yield (TTM)	-4.5%	-4.2%
Earnings Yield (TTM)	-4.4%	-3.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-56.7	0.0
EV/GP/RG	0.68	N/A
Ticker research	View IOVA research	View PRAX research